Jack Cuzick JACK CUZICK, Wolfson Institute of Preventive Medicine, London New data from the ATAC trial, which is testing anastrozole and tamoxifen in early breast cancer, have demonstrated the continued … Continue reading ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up